218 related articles for article (PubMed ID: 22155828)
1. A novel carbon monoxide-releasing molecule fully protects mice from severe malaria.
Pena AC; Penacho N; Mancio-Silva L; Neres R; Seixas JD; Fernandes AC; Romão CC; Mota MM; Bernardes GJ; Pamplona A
Antimicrob Agents Chemother; 2012 Mar; 56(3):1281-90. PubMed ID: 22155828
[TBL] [Abstract][Full Text] [Related]
2. Eugenol disrupts Plasmodium falciparum intracellular development during the erythrocytic cycle and protects against cerebral malaria.
Pontes KAO; Silva LS; Santos EC; Pinheiro AS; Teixeira DE; Peruchetti DB; Silva-Aguiar RP; Wendt CHC; Miranda KR; Coelho-de-Souza AN; Leal-Cardoso JH; Caruso-Neves C; Pinheiro AAS
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129813. PubMed ID: 33321150
[TBL] [Abstract][Full Text] [Related]
3. Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.
DellaValle B; Staalsoe T; Kurtzhals JA; Hempel C
PLoS One; 2013; 8(3):e59271. PubMed ID: 23555646
[TBL] [Abstract][Full Text] [Related]
4. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria.
Pamplona A; Ferreira A; Balla J; Jeney V; Balla G; Epiphanio S; Chora A; Rodrigues CD; Gregoire IP; Cunha-Rodrigues M; Portugal S; Soares MP; Mota MM
Nat Med; 2007 Jun; 13(6):703-10. PubMed ID: 17496899
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
[TBL] [Abstract][Full Text] [Related]
6. Toward a novel metal-based chemotherapy against tropical diseases. 3. Synthesis and antimalarial activity in vitro and in vivo of the new gold-chloroquine complex [Au(PPh3)(CQ)]PF6.
Navarro M; Pérez H; Sánchez-Delgado RA
J Med Chem; 1997 Jun; 40(12):1937-9. PubMed ID: 9191972
[No Abstract] [Full Text] [Related]
7. Control of disease tolerance to malaria by nitric oxide and carbon monoxide.
Jeney V; Ramos S; Bergman ML; Bechmann I; Tischer J; Ferreira A; Oliveira-Marques V; Janse CJ; Rebelo S; Cardoso S; Soares MP
Cell Rep; 2014 Jul; 8(1):126-36. PubMed ID: 24981859
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Guo J; Guiguemde AW; Bentura-Marciano A; Clark J; Haynes RK; Chan WC; Wong HN; Hunt NH; Guy RK; Golenser J
Antimicrob Agents Chemother; 2012 Jan; 56(1):163-73. PubMed ID: 22006004
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen activity against Plasmodium in vitro and in mice.
Weinstock A; Gallego-Delgado J; Gomes C; Sherman J; Nikain C; Gonzalez S; Fisher E; Rodriguez A
Malar J; 2019 Nov; 18(1):378. PubMed ID: 31775753
[TBL] [Abstract][Full Text] [Related]
10. Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes.
Sánchez-Delgado RA; Navarro M; Pérez H; Urbina JA
J Med Chem; 1996 Mar; 39(5):1095-99. PubMed ID: 8676344
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.
Wilson NO; Solomon W; Anderson L; Patrickson J; Pitts S; Bond V; Liu M; Stiles JK
PLoS One; 2013; 8(4):e60898. PubMed ID: 23630573
[TBL] [Abstract][Full Text] [Related]
12. VEGF promotes malaria-associated acute lung injury in mice.
Epiphanio S; Campos MG; Pamplona A; Carapau D; Pena AC; Ataíde R; Monteiro CA; Félix N; Costa-Silva A; Marinho CR; Dias S; Mota MM
PLoS Pathog; 2010 May; 6(5):e1000916. PubMed ID: 20502682
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.
John CC; Kutamba E; Mugarura K; Opoka RO
Expert Rev Anti Infect Ther; 2010 Sep; 8(9):997-1008. PubMed ID: 20818944
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
[TBL] [Abstract][Full Text] [Related]
15. Artemisone effective against murine cerebral malaria.
Waknine-Grinberg JH; Hunt N; Bentura-Marciano A; McQuillan JA; Chan HW; Chan WC; Barenholz Y; Haynes RK; Golenser J
Malar J; 2010 Aug; 9():227. PubMed ID: 20691118
[TBL] [Abstract][Full Text] [Related]
16. Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria.
Rodriguez AAM; Carvalho LJM; Kimura EA; Katzin AM
Int J Antimicrob Agents; 2018 Mar; 51(3):370-377. PubMed ID: 28843818
[TBL] [Abstract][Full Text] [Related]
17. Could Heme Oxygenase-1 Be a New Target for Therapeutic Intervention in Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome?
Pereira MLM; Marinho CRF; Epiphanio S
Front Cell Infect Microbiol; 2018; 8():161. PubMed ID: 29868517
[TBL] [Abstract][Full Text] [Related]
18. [Protective effects of artesunate combination on experimental cerebral malaria and nerve injury].
Jiang XH; Chen LN; Li K; Guo Y; Zheng ZY; Yang T; Zheng XJ; Li YJ; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3051-3057. PubMed ID: 30200698
[TBL] [Abstract][Full Text] [Related]
19. Sickle hemoglobin confers tolerance to Plasmodium infection.
Ferreira A; Marguti I; Bechmann I; Jeney V; Chora A; Palha NR; Rebelo S; Henri A; Beuzard Y; Soares MP
Cell; 2011 Apr; 145(3):398-409. PubMed ID: 21529713
[TBL] [Abstract][Full Text] [Related]
20. Rocaglates as dual-targeting agents for experimental cerebral malaria.
Langlais D; Cencic R; Moradin N; Kennedy JM; Ayi K; Brown LE; Crandall I; Tarry MJ; Schmeing M; Kain KC; Porco JA; Pelletier J; Gros P
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2366-E2375. PubMed ID: 29463745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
